Growth Metrics

Healthequity (HQY) Debt to Equity (2019 - 2026)

Healthequity has reported Debt to Equity over the past 8 years, most recently at $0.45 for Q1 2026.

  • For Q1 2026, Debt to Equity fell 9.03% year-over-year to $0.45; the TTM value through Jan 2026 reached $0.45, down 9.03%, while the annual FY2026 figure was $0.45, 9.03% down from the prior year.
  • Debt to Equity for Q1 2026 was $0.45 at Healthequity, down from $0.46 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.51 in Q3 2024 and troughed at $0.43 in Q1 2024.
  • A 5-year average of $0.48 and a median of $0.49 in 2023 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: fell 29.79% in 2022 and later rose 16.16% in 2025.
  • Year by year, Debt to Equity stood at $0.49 in 2022, then fell by 10.64% to $0.44 in 2023, then rose by 15.69% to $0.51 in 2024, then fell by 9.55% to $0.46 in 2025, then dropped by 1.28% to $0.45 in 2026.
  • Business Quant data shows Debt to Equity for HQY at $0.45 in Q1 2026, $0.46 in Q4 2025, and $0.47 in Q3 2025.